Arcturus Therapeutics Holdings (ARCT) Operating Income (QoQ) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) Operating Income (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.59% |
| Dec 31, 2025 | -89.60% |
| Sep 30, 2025 | -42.15% |
| Jun 30, 2025 | 30.96% |
| Mar 31, 2025 | 49.61% |
| Dec 31, 2024 | -211.02% |
| Sep 30, 2024 | 49.18% |
| Jun 30, 2024 | 30.53% |
| Mar 31, 2024 | -66.44% |
| Dec 31, 2023 | 5.40% |
| Sep 30, 2023 | 65.12% |
| Jun 30, 2023 | -475.29% |
| Mar 31, 2023 | -87.85% |
| Dec 31, 2022 | 429.97% |
| Sep 30, 2022 | -66.63% |
| Jun 30, 2022 | 56.15% |
| Mar 31, 2022 | -33.83% |
| Dec 31, 2021 | 30.06% |
| Sep 30, 2021 | -0.19% |
| Jun 30, 2021 | 6.84% |